Trillium Asset Management’s Transmedics TMDX Stock Holding History

Trillium Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.76M	Buy	41,577 +4,166	+11%	+$353K	0.09%	148
2026 Q1	$4.08M	Buy	37,411 +9,534	+34%	+$1.24M	0.14%	121
2025 Q4	$3.53M	Sell	27,877 -5,656	-17%	-$710K	0.11%	131
2025 Q3	$3.76M	Sell	33,533 -501	-1%	-$58.6K	0.1%	135
2025 Q2	$4.56M	Sell	34,034 -1,355	-4%	-$149K	0.12%	126
2025 Q1	$2.38M	Buy	35,389 +2,442	+7%	+$168K	0.07%	148
2024 Q4	$2.05M	Buy	32,947 +9,718	+42%	+$905K	0.05%	157
2024 Q3	$3.65M	Sell	23,229 -75	-0.3%	-$11.6K	0.09%	154
2024 Q2	$3.51M	Buy	+23,304	New	+$2.8M	0.09%	154

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Trillium Asset Management's TMDX Position: Q2 2026 in Review

Trillium Asset Management increased its Transmedics (TMDX) stake by 11% in Q2 2026, buying an estimated $353K and bringing the position to 41,577 shares worth $2.76M. The position accounts for 0.09% of the portfolio, ranked #148.

Trillium Asset Management first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.56M in Q2 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Trillium Asset Management held 41,577 shares of Transmedics worth $2.76M as of Q2 2026.
Trillium Asset Management bought 4,166 Transmedics shares in Q2 2026, an estimated $353K.
Transmedics made up 0.09% of Trillium Asset Management's portfolio in Q2 2026, its #148 holding.
Trillium Asset Management first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
Trillium Asset Management's Transmedics position peaked at $4.56M in Q2 2025.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Trillium Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.